Golden Nugget Online Gaming to Participate at the Bank of America Securities Sports Betting and Online Gaming Field Trip Virtual Conference

PR Newswire

HOUSTON, March 15, 2021 /PRNewswire/ — Golden Nugget Online Gaming, Inc. (NASDAQ: GNOG) today announced that it will participate at the Bank of America Securities Sports Betting and Online Gaming Field Trip Virtual Conference on March 16, 2021 at 9:00 a.m. Eastern Time.

Thomas Winter, President, will present on behalf of the Company.


About GNOG

Golden Nugget Online Gaming is a leading online gaming company that is considered a market leader by its peers and was first to bring Live Dealer and Live Casino Floor to the United States online gaming market. GNOG was the recipient of 15 eGaming Review North America Awards, including the coveted “Operator of the Year” award in 2017, 2018, 2019 and 2020.

Cision View original content:http://www.prnewswire.com/news-releases/golden-nugget-online-gaming-to-participate-at-the-bank-of-america-securities-sports-betting-and-online-gaming-field-trip-virtual-conference-301246907.html

SOURCE Golden Nugget Online Gaming, Inc.

CIBC Future Heroes Bursary Program now accepting applications until May 12

Canada NewsWire

Second year of bursary program part of bank’s $500,000 commitment to supporting health care students

TORONTO, March 15, 2021 /CNW/ – CIBC today announced that applications for the CIBC Future Heroes Bursary Program are now being accepted. The program  aims to help post-secondary students realize their ambitions of pursuing a career in health care. CIBC invested $500,000 over two academic years starting in 2020 in the education of tomorrow’s health care professionals.

Under the program, 125 entrance bursaries will be awarded for the 2021/2022 academic year. Each bursary recipient will receive a total of $2,500 toward one academic year.

“The past year has reinforced the need for us, as a country, to continue to invest in support for talent in healthcare and the development of future frontline workers. We are proud to continue supporting the education of the aspiring healthcare professionals of tomorrow,” said Stephen Forbes, Executive Vice-President, Purpose, Brand and Corporate Affairs. “On behalf of CIBC, we congratulate all 2020 bursary recipients and wish the best to the 2021 applicants. We look forward to seeing them achieve their goals to advance quality healthcare and make a difference in our communities.” 

The selection and administration of the bursaries is conducted by Universities Canada, and bursary recipients will receive their funds starting in August 2021.

Applications for first-year students, enrolled in eligible health care programs at one of the 50 partner post-secondary schools across Canada, will be accepted until May 12, 2021.

Post-secondary schools involved in the program include the following:

  • Atlantic: College of North Atlantic, Dalhousie University, Memorial University of Newfoundland, New Brunswick Community College, Nova Scotia Community College, University of New Brunswick, University of Prince Edward Island

  • Québec: McGill University, Université Laval, Université de Montréal, Université de Sherbrooke


  • Manitoba
    : Assiniboine Community College, Brandon University, Red River College, University College of the North, University of Manitoba, Université de Saint-Boniface


  • Alberta
    : Medicine Hat College, Portage College, Red Deer College, Southern Alberta Institute of Technology, University of Alberta, University of Calgary, University of Lethbridge


  • Ontario
    : Algonquin College, Centennial College, Confederation College, Lambton College, Laurentian University, McMaster University, Queen’s University, Sault College, Sheridan College, University of Toronto


  • Saskatchewan
    : Cumberland College, Northlands College, Parkland College, Saskatchewan Polytechnic, University of Regina, University of Saskatchewan


  • British Columbia
    : Camuson College, College of the Rockies, Thompson Rivers University, University of British Columbia, University of Northern British Columbia, University of Victoria, Vancouver Community College

  • Territories: Aurora College, Nunavut Arctic College, Yukon University

The CIBC Future Heroes Bursary Program is supported by the generous contributions of partners like Access Storage, the Aquilini Family, KingSett Capital, Momentum Solutions, Nutrien, Rogers, Teck and Telus, as well as CIBC employees and Canadians who donated towards the creation of additional bursaries.

About CIBC

CIBC is a leading North American financial institution with 10 million personal banking, business, public sector and institutional clients. United under the bank’s community investment initiative One for Change, CIBC and its team are committed to coming together to help people and communities realize their ambitions. In 2020, CIBC and its team invested $75 million in community organizations across Canada and the U.S. Ongoing news releases and more information about CIBC can be found at www.cibc.com/en/about-cibc/media-centre.html.

About Universities Canada

Universities Canada is the voice of Canada’s universities at home and abroad, advancing higher education, research and innovation for the benefit of all Canadians.

SOURCE CIBC

SOURCE CIBC

Pizza Hut Serves Up ‘Newstalgia’ with Campaign Celebrating All that Fans Know and Love About the Pizza Restaurant

Brand enlists Craig Robinson and unveils a limited-edition PAC-MAN box featuring augmented reality game and a chance to win a custom PAC-MAN game cabinet

PR Newswire

PLANO, Texas, March 15, 2021 /PRNewswire/ — Remember going to Pizza Hut as a kid? The glorious aroma of pizza enveloped you as you were led to a classic red booth decked out in a red and white checkered tablecloth under the cozy glow of a stained-glass Tiffany-style lamp. You’d score some quarters to play an arcade game as you waited for your Personal Pan Pizza®, served hot in a cast iron skillet. Life was good.

Pizza Hut is bringing back all the nostalgic feels to customers with a new brand campaign that captures the concept of “Newstalgia.” The campaign puts a contemporary twist on celebrating all the things people love and associate with the brand – from Book It!® pins, classic arcade games, red cups and Tiffany-style lamps and of course, iconic Pizza Hut pizzas.

To help launch the campaign, Pizza Hut teamed up with new spokesperson, Craig Robinson, for a TV spot featuring the actor/comedian playing a retro PAC-MAN game while enjoying a $10 Tastemaker™ pizza. In a modern twist, Pizza Hut has partnered with PAC-MAN to offer a limited-edition PAC-MAN box, featuring an augmented reality version of the iconic game printed directly on the packaging that fans can play using their smartphones.


#PizzaHutARcade

Beginning today, fans who play the AR PAC-MAN game can enter for a chance to win their very own custom Arcade1Up PAC-MAN game cabinet. Here’s how it works:

Order a large pizza from Pizza Hut. Scan the QR code on limited-edition PAC-MAN box and play the awesome AR PAC-MAN game.  Then, to enter the sweepstakes, follow the on-screen prompts to share your score with @PizzaHut on Twitter using #PizzaHutARcade #Sweepstakes. The best part? You don’t need to be a PAC-MAN wiz to win! No matter your high score, as long as you share it, you have a chance to win. Limited-edition PAC-MAN box available while supplies last. For additional information, restrictions, and full Official Rules, visit here.1  

On April 3, Pizza Hut will randomly select one lucky winner from all eligible entries properly submitted to receive the custom PAC-MAN arcade game cabinet for their home.

“PAC-MAN’s design and creation was inspired by the shape of a pizza with a slice taken out of it, making this partnership so appropriate for the PAC-MAN brand,” said Yutaka Fuse, Head of Licensing and Branding at BANDAI NAMCO Entertainment Inc. “PAC-MAN games and Pizza Hut pizzas occupy a special place in many people’s memories; we’re excited to have the opportunity to create fun memories for a new generation of PAC-MAN and Pizza Hut fans through this collaboration.”


The Ultimate Pizza Lover

To kick off the campaign, Pizza Hut joined forces with actor and comedian, Craig Robinson. Robinson will be the face of Pizza Hut, and the campaign for the rest of the year. He can be seen embodying  that ‘kid at heart’ and ultimate pizza lover in the new TV spot “Dots,” as he enjoys a $10 Tastemaker pizza while playing a vintage PAC-MAN tabletop game – just like the old days dining in at Pizza Hut.

“Everyone has their own special Pizza Hut memory – from being a BOOK IT! kid or grabbing post-game pizza with your little league buddies,” Robinson said. “Growing up in the 80s, mine was going into Pizza Hut and devouring those little PAC-MAN dots just like I did my pizza. Those arcade games in the restaurant – there was nothing better as a kid.”

“There aren’t many brands with more iconic elements than us, whether it’s the red cups, checkered tablecloths, connection to pop culture and entertainment – like PAC-MAN – or our iconic Pan Pizza,” said George Felix, Chief Marketing Officer, Pizza Hut. “As we look to connect with a new generation of pizza lovers, we are tapping into those things that make Pizza Hut great in a modern and relevant way.”

The PAC-MAN box, AR game and TV spot are just the beginning. Throughout the year, Pizza Hut will be fueling pizza lovers with new innovation, bringing back iconic pizzas and tapping into entertainment and pop culture in new and unexpected ways. Hurry and get your $10 Tastemaker in the limited-edition PAC-MAN box today!


About Pizza Hut®

Pizza Hut, a subsidiary of Yum! Brands, Inc. (NYSE: YUM), has more restaurant locations in the world than any other pizza company. Founded in 1958 in Wichita, Kan., Pizza Hut operates nearly 18,000 restaurants in more than 100 countries. With easy order options including the Pizza Hut app, mobile site, and Amazon and Google devices, Pizza Hut is committed to providing an easy pizza experience – from order to delivery – and has Hut Rewards, the Pizza Hut loyalty program that offers points for every dollar spent on food any way you order.

Now more than ever, restaurants have an important role in helping to safely feed families. As the largest pizza brand in the U.S. by store count, Pizza Hut is committed to doing its part. To help keep team members and customers safe, customers can get their favorite Pizza Hut pizza via three contactless offerings: curbside pickup, delivery, or carryout. Additionally, restaurant locations continue to implement health and safety procedures including advising guest-facing team members to wear single-use personal protective gear, pizza box safety seals, pre-shift temperature checks, and counter shields to increase protection between customers and employees.

Pizza Hut is also the proprietor of The Literacy Project, an initiative designed to enable access, empower teachers and inspire a lifelong love of reading. The program is rooted in the foundation set by the Pizza Hut BOOK IT! Program, which is the longest-running corporate supported literacy program, impacting more than 14 million students each year. Pizza Hut is the Official and Only Pizza Sponsor of the NFL and NCAA®.

For more information about Pizza Hut, visit www.pizzahut.com or http://www.pizzahut.com/c/content/sitemap


About BANDAI NAMCO Entertainment America Inc.

BANDAI NAMCO Entertainment America Inc., part of BANDAI NAMCO Holdings Inc., is a leading global publisher and developer of interactive entertainment for all major video game consoles, iOS, Android, and online platforms. The company is known for creating and publishing many of the industry’s top video game franchises including PAC-MAN®, GALAGA®, TEKKEN®, SOULCALIBUR®, and ACE COMBAT®. BANDAI NAMCO Entertainment America Inc. is the premier publisher in the Western hemisphere for anime based video games including NARUTO SHIPPUDEN™, DRAGON BALL Z®, and ONE PIECE®. More information about the company and its products can be found at http://www.bandainamcoent.com or www.facebook.com/BandaiNamcoUS.


About PAC-MAN

Born on May 22, 1980, PAC-MAN immediately rose to meteoric popularity, first in video game arcades, then on the pop culture stage and through an array of branding and entertainment appearances throughout the 1980’s and 1990’s.

2020 marked PAC-MAN’s 40th anniversary and with a global brand recognition rate of 90%, PAC-MAN’s image and brand continues to be one of the most beloved and recognized on the planet. PAC-MAN continues to entertain and delight fans – of all generations – with new video game offerings, innovative brand partnerships, and creative collaborations.

To learn more about PAC-MAN, please visit:  https://www.pacman.com/en/. You can also follow PAC-MAN on Facebook at: https://www.facebook.com/pacman/, on Twitter at: https://twitter.com/officialpacman?lang=en, or on Instagram at: https://www.instagram.com/officialpacman/?hl=en.

PAC-MAN®&©BANDAI NAMCO Entertainment Inc.

Contact:
Brett LeVecchio, Pizza Hut
972.338.6730 / [email protected]

1 No purchase necessary. For additional information, restrictions, and full Official Rules, visit here.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/pizza-hut-serves-up-newstalgia-with-campaign-celebrating-all-that-fans-know-and-love-about-the-pizza-restaurant-301246956.html

SOURCE Pizza Hut

Dana Earns Recognition as John Deere ‘Partner-level,’ Hall of Fame Supplier

PR Newswire

MAUMEE, Ohio, March 15, 2021 /PRNewswire/ — Dana’s operations in Crescentino, Italy, have earned recognition as a Partner-level supplier for 2020 and was inducted into the Supplier Hall of Fame in the John Deere Achieving Excellence Program. 

Hall of Fame status is given after a supplier attains a Partner-level rating for five consecutive years.  The Partner-level status is Deere & Company’s highest supplier rating. 

Dana was selected for the honor in recognition of its dedication to providing products and service of outstanding quality, as well as its commitment to continuous improvement.  Company employees accepted the recognition during virtual ceremonies held in Mannheim, Germany.

“Our relationship with John Deere builds on our commitment to collaborative innovation and integrated technologies that maximize performance, efficiency, and durability,” said Aziz Aghili, executive vice president and president of Dana Off-Highway Drive and Motion Systems.  “We are honored to be recognized as a John Deere Hall of Fame Supplier and remain committed to continuous improvement and reimagining what’s possible to meet our customers’ needs.”

Dana is a supplier of axles, driveshafts, planetary drives, sealing and thermal products, and other components to John Deere’s operations globally, serving the agriculture and construction markets. 

Suppliers who participate in the Achieving Excellence Program are evaluated annually in several key performance categories, including quality, cost management, delivery, technical support and wavelength, which is a measure of responsiveness.

About Dana Incorporated
Dana is a leader in the design and manufacture of highly efficient propulsion and energy-management solutions for all mobility markets across the globe.  The company’s conventional and clean-energy solutions support nearly every vehicle manufacturer with drive and motion systems; electrodynamic technologies, including software and controls; and thermal, sealing, and digital solutions.

Based in Maumee, Ohio, USA, the company reported sales of $7.1 billion in 2020 with 38,000 associates in 33 countries across six continents.  Founded in 1904, Dana was named one of “America’s Most Responsible Companies 2021” by Newsweek for its emphasis on sustainability and social responsibility.  The company is driven by a high-performance culture that focuses on its people, which has earned it global recognition as a top employer, including “World’s Best Employer’ from Forbes magazine.  Learn more at dana.com.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/dana-earns-recognition-as-john-deere-partner-level-hall-of-fame-supplier-301246599.html

SOURCE Dana Incorporated

OTC Markets Group Welcomes Uwharrie Capital Corp to OTCQX

PR Newswire

NEW YORK, March 15, 2021 /PRNewswire/ — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Uwharrie Capital Corp (OTCQX: UWHR), the bank holding company for Uwharrie Bank, has qualified to trade on the OTCQX® Best Market. Uwharrie Capital Corp upgraded to OTCQX from the Pink® market.

Uwharrie Capital Corp begins trading today on OTCQX under the symbol “UWHR.”  U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

Graduating to the OTCQX Market marks an important milestone for community banks in the U.S. public markets. The OTCQX Market enables banks to maximize the value of being a public company by providing transparent trading and easy access to company information for shareholders. To qualify for OTCQX, community banks must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws.

Roger Dick, Chief Executive Officer of Uwharrie Capital Corp said, “The founding mission of Uwharrie Capital Corp still holds true, to help create robust local economies that help our neighbors obtain a quality of life that promotes traditional values; values that inspire us to care for one another and create opportunities where our children and grandchildren can achieve financial security. To us, it’s about more than a bottom line, it’s about Making a Difference®.”

“We think that’s a story worth telling on a broader stage. By joining the OTCQX, it is our intent to enhance share value to all shareholders and highlight Uwharrie’s long-term commitment to the communities we serve,” commented David Beaver, Chief Financial Officer of Uwharrie Capital Corp.

Raymond James & Associates Inc. acted as the company’s OTCQX sponsor.

About Uwharrie Capital Corp
Uwharrie Capital Corp offers a full range of financial solutions through its subsidiaries: Uwharrie Bank and Uwharrie Investment Advisors.

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market and the Pink® Open Market for 11,000 U.S. and global securities.  Through OTC Link® ATS and OTC Link ECN, we connect a diverse network of broker-dealers that provide liquidity and execution services.  We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.

To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.

OTC Link ATS and OTC Link ECN are SEC regulated ATSs, operated by OTC Link LLC, member FINRA/SIPC.

Subscribe to the OTC Markets RSS Feed

Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428, [email protected] 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/otc-markets-group-welcomes-uwharrie-capital-corp-to-otcqx-301247073.html

SOURCE OTC Markets Group Inc.

The9 Appointed Wang Wei as the Vice President of NBTC Limited

PR Newswire

SHANGHAI, March 15, 2021 /PRNewswire/ — The9 Limited (Nasdaq: NCTY) (“The9”), an established Internet company, today announced the appointment of Mr. Wang Wei as the Vice President of NBTC Limited (hereinafter referred to as “NBTC”), a wholly-owned subsidiary of The9. Mr. Wang will lead the global operation and management of the cryptocurrencies mining machines in NBTC.

Mr. Wang is an early pioneer in the blockchain industry. Before joining The9, he served as the head of Canaan Technology’s technical service center, leading the team responsible for the maintenance and after-sales service of hundreds of thousands of mining machines. At the same time, Mr. Wang’s team assisted customers in building and upgrading blockchain supercomputing centers.

After joining the NBTC team in The9, Mr. Wang will be responsible for the strategic global operation and management of the cryptocurrencies mining machines, including deployment and management of mining machines, network equipment and mining facilities, and the development of operation strategy for different types of cryptocurrencies mining machines in different mining facilities and the cooperation with different mining pools to improve the operation and maintenance efficiency, ensure asset safety, and generate various reports for decision making. Also from a technical point of view, Mr. Wang will work with the management team to formulate the development strategy and execution plan of the cryptocurrencies mining business.

In January this year, The9 announced the establishment of the wholly-owned subsidiary NBTC to engage in blockchain and cryptocurrency related businesses. Since then NBTC has quickly and continuously purchased Bitcoin and Filecoin mining machines, in order to achieve The9’s global hash rate goal in cryptocurrencies mining.

About The9 Limited

The9 Limited (The9) is an Internet company based in China listed on Nasdaq in 2004. The9 aims to become a diversified high-tech Internet company.

Cision View original content:http://www.prnewswire.com/news-releases/the9-appointed-wang-wei-as-the-vice-president-of-nbtc-limited-301247174.html

SOURCE The9 Limited

Windtree to Present at the Oppenheimer 31st Annual Healthcare Conference

PR Newswire

WARRINGTON, Pa., March 15, 2021 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that Craig Fraser, president and chief executive officer, will present at the Oppenheimer 31st Annual Healthcare Conference and be available for 1×1 meetings. Details are as follows:

Oppenheimer 31st Annual Healthcare Conference
Date:                Tuesday, March 16, 2021
Time:               10:40 AM Eastern Time
Webcast:         To register, click on the link HERE

A live audio webcast will be available via the events page of the Windtree website at http://windtreetx.investorroom.com/events. A replay of the presentation will be archived on the Windtree website for 30 days for those unable to listen live.

About Windtree Therapeutics
Windtree Therapeutics, Inc. is advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders to treat patients in moments of crisis. Using new clinical approaches, Windtree is developing a multi-asset franchise anchored around compounds with an ability to activate SERCA2a, with lead candidate istaroxime being developed as a first-in-class treatment for acute heart failure and early cardiogenic shock in heart failure. Windtree has also focused on developing AEROSURF® as a non-invasive surfactant treatment for premature infants with respiratory distress syndrome, and is facilitating transfer of clinical development of AEROSURF® to its licensee in Asia, Lee’s HK, while Windtree  evaluates other uses for its synthetic KL4 surfactant for the treatment of acute pulmonary conditions including lung injury due to viral, chemical and radiation induced insults. Also, in its portfolio is rostafuroxin, a novel precision drug product targeting hypertensive patients with certain genetic profiles.

For more information, please visit the Company’s website at www.windtreetx.com.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/windtree-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-301246440.html

SOURCE Windtree Therapeutics, Inc.

Benchmark Electronics Announces Quarterly Cash Dividend

First quarter 2021 cash dividend of $0.16 per share

PR Newswire

TEMPE, Ariz., March 15, 2021 /PRNewswire/ — Benchmark Electronics, Inc. (NYSE: BHE) today announced that its Board of Directors declared a quarterly dividend of $0.16 per share, payable on April 14, 2021 to shareholders of record at the close of business on March 31, 2021.

About Benchmark Electronics, Inc.

Benchmark provides comprehensive solutions across the entire product life cycle by leading through its innovative technology and engineering design services, leveraging its optimized global supply chain and delivering world-class manufacturing services in the following industries: commercial aerospace, defense, advanced computing, next generation telecommunications, complex industrials, medical, and semiconductor capital equipment. Benchmark’s global operations include facilities in seven countries and its common shares trade on the New York Stock Exchange under the symbol BHE.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/benchmark-electronics-announces-quarterly-cash-dividend-301246397.html

SOURCE Benchmark Electronics, Inc.

Update on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics

NEW YORK, March 15, 2021 (GLOBE NEWSWIRE) — Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, provides an update on the establishment of the Medicare Coverage of Innovative Technology (MCIT) pathway to provide a coverage pathway for Medicare beneficiaries nationwide for innovative medical devices and diagnostic tests designated under the Breakthrough Device review program and with market authorization by the U.S. Food and Drug Administration (FDA).

Centers for Medicare & Medicaid Services (CMS) will delay the implementation date of the MCIT rule by 60 days, beginning a 30-day comment period to solicit additional public feedback on the rule. RenalytixAI expects the MCIT rule, as is or amended, will become effective within the expected 2021 FDA review and clearance period for KidneyIntelX and will have no material effect on the RenalytixAI business plan.  

RenalytixAI’s lead product, KidneyIntelX, was granted FDA breakthrough designation in May 2019 and submitted its final FDA application in August 2020. The MCIT rule has bipartisan support in Congress and is considered by many as a key program to drive medical innovation and improve countless lives. Further background and details are contained in the Company’s announcement on January 13, 2021.


For further information, please contact:

Renalytix AI plc  www.renalytixai.com
James McCullough, CEO Via Walbrook PR
   
Stifel (Nominated Adviser, Joint Broker) Tel: 020 7710 7600
Alex Price / Nicholas Moore  
   
Investec Bank plc (Joint Broker) Tel: 020 7597 4000
Gary Clarence / Daniel Adams  
   
Walbrook PR Limited Tel: 020 7933 8780 or [email protected]
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584 391 303

About Kidney Disease

Kidney disease is now recognized as a public health epidemic affecting over 850 million people globally. The Centers for Disease Control and Prevention (CDC) estimates that 15% of US adults, or 37 million people, currently have chronic kidney disease (CKD). Further, the CDC reports that 9 out of 10 adults with CKD do not know they have it and 1 out of 2 people with very low kidney function who are not on dialysis do not know they have CKD*. Kidney disease is referred to as a “silent killer” because it often has no symptoms and can go undetected until a very advanced stage. Each year, kidney disease kills more people than breast and prostate cancer. Every day, 13 patients in the United States die while waiting for a kidney transplant.

* https://www.cdc.gov/kidneydisease/publications-resources/2019-national-facts.html

About RenalytixAI

RenalytixAI (LSE: RENX) (NASDAQ: RNLX) is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The Company’s lead product is KidneyIntelX.com (visit www.kidneyintelx.com) which is being designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. For more information, visit www.renalytixai.com


Forward-Looking Statements


Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Examples of these forward-looking statements include statements concerning: the potential for KidneyIntelX to receive regulatory approval from the FDA, the commercial prospects of KidneyIntelX, if approved, including whether KidneyIntelX will be successfully distributed and marketed, our ability to take advantage of the MCIT program, our expectations regarding the timing and impact of the MCIT rule, our expectations regarding reimbursement decisions and the ability of KidneyIntelX to curtail costs of chronic and end-stage kidney disease, optimize care delivery and improve patient outcomes. Words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “seeks,” and similar expressions are intended to identify forward-looking statements. We may not actually achieve the plans and objectives disclosed in the forward-looking statements, and you should not place undue reliance on our forward-looking statements. Any forward-looking statements are based on management’s current views and assumptions and involve risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. These risks and uncertainties include, among others: that KidneyIntelX is based on novel artificial intelligence technologies that are rapidly evolving and potential acceptance, utility and clinical practice remains uncertain; we have only recently commercially launched KidneyIntelX; and risks relating to the impact on our business of the COVID-19 pandemic or similar public health crises. These and other risks are described more fully in our filings with the Securities and Exchange Commission (SEC), including the “Risk Factors” section of our annual report on Form 20-F filed with the SEC on October 28, 2020, and other filings we make with the SEC from time to time. All information in this press release is as of the date of the release, and we undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.

Media Contact:

United States:
Jennifer Moritz
Zer0 to 5ive for RenalytixAI
(917) 748-4006
[email protected] 



ALX Oncology Announces Appointment of Sophia Randolph, M.D., Ph.D., to Board of Directors

BURLINGAME, Calif., March 15, 2021 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced the appointment of Sophia Randolph, M.D., Ph.D., to its Board of Directors. Dr. Randolph brings over fifteen years of biopharmaceutical industry experience and serves as Chief Medical Officer of ALX Oncology and will continue in this role.

“Dr. Randolph brings significant pharmaceutical research and development expertise to ALX Oncology and has been a crucial member of our management team over the last five years,” said Corey Goodman, Ph.D., Executive Chairman of ALX Oncology. “This appointment represents another strong addition to our Board of Directors and complements the expertise of the current board members, as well as adding a valuable new perspective, and positions us well for continued clinical development and growth.”

“It is a privilege to be joining ALX Oncology’s Board of Directors and contribute to corporate strategy as ALX prepares to initiate numerous clinical trials this year,” said Sophia Randolph, M.D., Ph.D., Chief Medical Officer of ALX Oncology. “I look forward to working closely with the Board and continuing my role as Chief Medical Officer through what I believe will be a momentous time for the Company, while making a positive impact on people living with cancer.”

Dr. Randolph has served as the Chief Medical Officer of ALX Oncology since June 2016. Prior to joining us, she was with Pfizer Oncology Early and Late Development Groups, where she served most recently as Executive Director, Oncology and was the global clinical franchise lead for Ibrance® (palbociclib) at Pfizer, where she oversaw the program from first-in-human trials to regulatory approval. Previously, Dr. Randolph was Director, Clinical Sciences, Oncology at Merck & Co., Inc. She holds an A.B. in Biochemistry from Harvard University and an M.D. and a Ph.D. in Cellular and Molecular Biology from the University of Michigan. Dr. Randolph completed her oncology fellowship training at Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research Center.

About ALX Oncology

ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. ALX Oncology’s lead product candidate, ALX148, is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. ALX148 has demonstrated promising clinical responses across a range of hematologic and solid malignancies in combination with a number of leading anti-cancer agents. ALX Oncology intends to continue clinical development of ALX148 for the treatment of a range of solid tumor indications as well as MDS and AML. For more information, please visit ALX Oncology’s website at www.alxoncology.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements are based on ALX Oncology’s beliefs and assumptions and on information currently available to it on the date of this press release. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause ALX Oncology’s actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. These statements include but are not limited to statements regarding ALX Oncology’s clinical pipeline and the expectations regarding the beneficial characteristics, safety, efficacy and therapeutic effects of ALX148 in addition to key milestones such as anticipated clinical trial data readouts and cash and other financial expectations. These and other risks are described more fully in ALX Oncology’s filings with the Securities and Exchange Commission (“SEC”), including ALX Oncology’s Quarterly Report on Form 10-Q, filed with the SEC on November 12, 2020, and other documents ALX Oncology subsequently files with the SEC from time to time. Except to the extent required by law, ALX Oncology undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.



Investor Contact:

Peter Garcia
Chief Financial Officer, ALX Oncology
(650) 466-7125 Ext. 113
[email protected]

Argot Partners
(212)-600-1902
[email protected]

Media Contact:

Karen Sharma
MacDougall
(781) 235-3060
[email protected]